Tongue cancer tailored photosensitizers for NIR-II fluorescence imaging guided precise treatment

Baoli Yin,Qiaoqiao Qin,Zhe Li,Youjuan Wang,Xinlin Liu,Yongchao Liu,Shuangyan Huan,Xiaobing Zhang,Guosheng Song,Baoli Yin,Qiaoqiao Qin,Zhe Li,Youjuan Wang,Xinlin Liu,Yongchao Liu,Shuangyan Huan,Xiaobing Zhang,Guosheng Song
DOI: https://doi.org/10.1016/j.nantod.2022.101550
IF: 17.4
2022-08-01
Nano Today
Abstract:Although several photosensitizers have been used for photodynamic therapy (PDT) of tongue cancer, the treatment efficacy was still suffered from the short excitation wavelength of photosensitizer, low reactive oxygen species (ROS) yield in hypoxic tumor microenvironment and lack of monitoring method. Herein, by introducing two electron - deficient groups (A) on D-A′-D core, a novel near-infrared II (NIR-II) molecule with A-D-A′-D-A configuration is developed. Via the rational design of molecular structure, NIR-II molecule exhibits excellent properties: i) The intramolecular multiple “push-pull” interactions and the enlargement of conjugated system results in the absorption wavelength red-shift, so that the photosensitizers could be effectively excited by NIR laser (808 nm). ii) The reduced ΔEST promotes the intersystem crossing (ISC) process and enables high-efficient generation of ·OH via Type I PDT, addressing the limitation of hypoxic tumor. iii) The high emission of NIR-II fluorescence and excellent optical stability endow the repeated NIR-II imaging to report the precise localization of tongue tumor for guiding laser irradiation and monitoring treatment, so as to achieve precise dose and timing of administration and minimize the side effect. Therefore, this work will provide insights into design of tongue cancer tailored photosensitizers for precise and effective therapy.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?
This paper aims to solve several key problems in photodynamic therapy (PDT) for tongue cancer: 1. **Shorter excitation wavelength**: Existing photosensitizers have a shorter excitation wavelength, so it is difficult for them to effectively penetrate tissues, especially in the treatment of deep - seated or large tumors, the effect is not good. 2. **Low reactive oxygen species (ROS) production rate**: In the hypoxic tumor micro - environment, the production rate of reactive oxygen species (ROS) generated by traditional photosensitizers is low, which affects the treatment effect. 3. **Lack of effective monitoring methods**: At present, there is a lack of effective monitoring means to guide the process of photodynamic therapy, resulting in the difficulty of accurately controlling the treatment dose and time, which may cause over - treatment or under - treatment. To solve the above problems, the author designed a new near - infrared II region (NIR - II) molecule. By introducing two electron - acceptor groups (A), a molecule with an A - D - A′ - D - A structure was formed. This molecule has the following advantages: - **Red - shifted absorption wavelength**: Through multiple "push - pull" interactions within the molecule and the expansion of the conjugated system, the photosensitizer can be effectively excited by an 808 - nm near - infrared laser. - **Enhanced singlet oxygen generation ability**: By reducing the energy difference between the singlet and triplet states (ΔE<sub>S1 - T2</sub>), the intersystem crossing process is promoted, thereby achieving efficient singlet oxygen (<sup>1</sup>O<sub>2</sub>) generation. - **High fluorescence emission and photostability**: The NIR - II molecule has a high fluorescence emission intensity and good photostability, and can be used for repeated NIR - II imaging to report the precise location of the tumor in real - time, guide laser irradiation, and monitor the treatment effect. In addition, this molecule can also generate hydroxyl radicals (·OH) through Type I photodynamic effect, which helps to overcome the limitations of photodynamic therapy under hypoxic conditions. These characteristics make this molecule show significant advantages in the precise treatment of tongue cancer.